21814-GO

GO ID: 
GO:0001568
GO:0001701
GO:0001824
GO:0001837
GO:0001889
GO:0003347
GO:0005024
GO:0005114
GO:0005160
GO:0005515
GO:0005539
GO:0005576
GO:0005578
GO:0005615
GO:0005737
GO:0005783
GO:0005886
GO:0005887
GO:0006461
GO:0006468
GO:0006955
GO:0007179
GO:0007181
GO:0008201
GO:0009790
GO:0009897
GO:0009986
GO:0010633
GO:0010719
GO:0015026
GO:0016020
GO:0016021
GO:0016049
GO:0017134
GO:0030165
GO:0030509
GO:0030511
GO:0030512
GO:0032354
GO:0034673
GO:0034695
GO:0034699
GO:0035556
GO:0043393
GO:0046332
GO:0048185
GO:0050431
GO:0050680
GO:0050880
GO:0051092
GO:0051271
GO:0055010
GO:0060021
GO:0060038
GO:0060216
GO:0060317
GO:0060318
GO:0060347
GO:0060389
GO:0060976
GO:0060977
GO:0060979
GO:0061032
GO:0070123
Evidence: 
IMP
IDA
ISO
TAS
IPI
IEA
Gene ID: 
21814
Definition: 
blood vessel development
in utero embryonic development
blastocyst development
epithelial to mesenchymal transition
liver development
epicardial cell to mesenchymal cell transition
transforming growth factor beta-activated receptor activity
type II transforming growth factor beta receptor binding
transforming growth factor beta receptor binding
protein binding
glycosaminoglycan binding
extracellular region
proteinaceous extracellular matrix
extracellular space
cytoplasm
endoplasmic reticulum
plasma membrane
integral component of plasma membrane
protein complex assembly
protein phosphorylation
immune response
transforming growth factor beta receptor signaling pathway
transforming growth factor beta receptor complex assembly
heparin binding
embryo development
external side of plasma membrane
cell surface
negative regulation of epithelial cell migration
negative regulation of epithelial to mesenchymal transition
coreceptor activity
membrane
integral component of membrane
cell growth
fibroblast growth factor binding
PDZ domain binding
BMP signaling pathway
positive regulation of transforming growth factor beta receptor signaling pathway
negative regulation of transforming growth factor beta receptor signaling pathway
response to follicle-stimulating hormone
inhibin-betaglycan-ActRII complex
response to prostaglandin E
response to luteinizing hormone
intracellular signal transduction
regulation of protein binding
SMAD binding
activin binding
transforming growth factor beta binding
negative regulation of epithelial cell proliferation
regulation of blood vessel size
positive regulation of NF-kappaB transcription factor activity
negative regulation of cellular component movement
ventricular cardiac muscle tissue morphogenesis
palate development
cardiac muscle cell proliferation
definitive hemopoiesis
cardiac epithelial to mesenchymal transition
definitive erythrocyte differentiation
heart trabecula formation
pathway-restricted SMAD protein phosphorylation
coronary vasculature development
coronary vasculature morphogenesis
vasculogenesis involved in coronary vascular morphogenesis
visceral serous pericardium development
transforming growth factor beta receptor activity, type III
GO Category: 
Process
Function
Component